End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.7 CLP | -.--% | -.--% | +46.27% |
03-16 | Essbio S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Essbio S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Sales 2022 | 219B 238M 18.72B | Sales 2023 | 234B 255M 20B | Capitalization | 266B 289M 22.72B |
---|---|---|---|---|---|
Net income 2022 | 7.15B 7.79M 612M | Net income 2023 | 29.68B 32.33M 2.54B | EV / Sales 2022 | 3.68 x |
Net Debt 2022 | 498B 542M 42.57B | Net Debt 2023 | 544B 592M 46.53B | EV / Sales 2023 | 3.46 x |
P/E ratio 2022 |
43.1
x | P/E ratio 2023 |
8.95
x | Employees | 1,293 |
Yield 2022 |
2.32% | Yield 2023 |
8.99% | Free-Float | 93.91% |
1 month | +47.74% | ||
3 months | +47.74% | ||
6 months | +46.27% | ||
Current year | +46.27% |
Date | Price | Change |
---|---|---|
31/05/24 | 14.7 | -.--% |
30/05/24 | 14.7 | -.--% |
29/05/24 | 14.7 | -.--% |
28/05/24 | 14.7 | -.--% |
27/05/24 | 14.7 | -.--% |
End-of-day quote Santiago S.E., May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+46.27% | 423M | |
-2.00% | 9.63B | |
-7.48% | 9.08B | |
-4.11% | 8.82B | |
+29.88% | 3.03B | |
+8.92% | 2.97B | |
-3.82% | 2.88B | |
-8.49% | 2.74B | |
-17.23% | 2.26B | |
+23.74% | 1.92B |
- Stock Market
- Equities
- ESSBIO-C Stock